Physician profile
David Bingham
NPI 1033345251
$11,600.21
in general payments reported to CMS, 2019-2025
6 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Psychiatric/Mental Health, Adult (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $659 · 2022: $53.05 · 2023: $11K · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,500 · Travel and Lodging: $1,255 · Food and Beverage: $1,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,500.00 |
| Travel and Lodging | $1,255.29 |
| Food and Beverage | $1,132.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $11,050.45 | 2021-2023 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $181.65 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $163.02 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $83.88 | 2025 | Abilify Asimtufii, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $68.16 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $53.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.